The global oscillating positive expiratory pressure (opep) devices market was estimated to be worth US$ 128.8 million in 2021 and is anticipated to increase to US$ 195.2 million by 2029, increasing at ...
Adjunctive therapy with a positive expiratory pressure (PEP) device may possibly decrease the length of hospital stays for patients with acute exacerbation of chronic obstructive pulmonary disease ...
Please provide your email address to receive an email when new articles are posted on . In more than 70% of patients with COPD, a positive expiratory pressure device improved exertional dyspnea. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback